Banzai International Inc Fair Value (InvestingPro)

The following section summarizes insights on Banzai International Inc's Fair Value (InvestingPro):

• ADMA Biologics's latest twelve months revenue is 426.5 million
• ADMA Biologics's revenue for fiscal years ending December 2020 to 2024 averaged 192.4 million.
• ADMA Biologics's operated at median revenue of 154.1 million from fiscal years ending December 2020 to 2024.
• Looking back at the last 5 years, ADMA Biologics's revenue peaked in December 2024 at 426.5 million.
• ADMA Biologics's revenue hit its 5-year low in December 2020 of 42.22 million.
• ADMA Biologics's revenue increased in each of the last 5 fiscal years from 42.22 million in 2020 to 426.5 million in 2024.